Merus Announces Financial Results for the Third Quarter 2024 and Provides Business Update
Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling...
Clinical Trial
Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference
Late-breaking presentation highlights the pTau217 assay as an effective and efficient tool to screen participants for ALTITUDE-AD that reduces unnecessary...
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
BURLINGTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome...
Biosimulation Market to Hit USD 9.18 Billion by 2029 with 16.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 30, 2024 /PRNewswire/ -- The global biosimulation market is projected to reach USD 9.18 billion by 2029...
Exostar Surpasses One Million Active Users on The Exostar Platform
Communities in Highly Regulated Industries Rely on Trusted, Proven Solution to Collaborate Securely and Compliantly HERNDON, Va., Oct. 30, 2024...
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D’Amelio
Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif., Oct. 30,...
The Alliance for Multispecialty Research (AMR) Deploys Advarra’s Site Training and Engagement Solution Across Its Network of 30+ Clinical Research Centers to Improve Staff Experience and Accelerate Study Startup
COLUMBIA, Md., Oct. 30, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites,...
WCG Unveils Major Enhancements to the Industry-Leading Site Network
PRINCETON, N.J., Oct. 30, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research,...
Signant Health and SPRIM PRO Align to Advance eClinical Solutions for Specialized Clinical Research
PHILADELPHIA, Oct. 30, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, today announced a...
PhaseV Appoints Head of Business Development Amid Growing Demand for its ML-Powered Clinical Trial Optimization Platform
Former PathAI Business Development Senior Director Hamza Sheikh Joins Company to Support Growing Customer Base and Strengthen Global Impact BOSTON,...
InsightRX to Present Abstracts On Vancomycin Pharmacokinetic Model Performance, MIPD Protocols at ACoP15 Conference
SAN FRANCISCO, Oct. 29, 2024 /PRNewswire/ -- InsightRX – the leader in Bayesian model-informed precision dosing (MIPD) software – today announced it...
PIECES TECHNOLOGIES AWARDED $2M FROM NATIONAL CANCER INSTITUTE, PART OF THE NATIONAL INSTITUTES OF HEALTH, TO ADVANCE USE OF CONVERSATIONAL AI TO IMPROVE THE CARE OF CANCER PATIENTS
Pieces will deploy new conversational AI at MetroHealth that will interact directly with cancer patients and leverage pioneering human oversight...
Cellev8 and Zyppah Team Up to Give Snoring a Rest
Cellev8 and Zyppah Announce Collaborative Sales Agreement Targeting 90 Million Snoring Americans.WELLINGTON, FL / ACCESSWIRE / October 29, 2024 /...
Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
SEATTLE WA AND LUND, SWEDEN / ACCESSWIRE / October 29, 2024 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB...
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today...
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos...
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical...
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)
RMAT Designation Follows Positive Proof-of-Concept Data from the ALLO-316 TRAVERSE Trial in Adult Patients with Advanced or Metastatic CD70 Positive...
NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Newly analyzed biomarker data from the initial dose-escalation Phase 1 AD trial found that troculeucel reduces GFAP, NfL, p-tau181, GDF-15,...
Immutep Quarterly Activities Report Q1 FY25
Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding...